Zhejiang Anglikang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
002940SZSE
Notice on the Disclosure of the Revised Plan for Issuing A Shares to Specific Targets in 2025
✨ AI Summary
Zhejiang Anglikang Pharmaceutical Co., Ltd. announced the approval of a revised plan for issuing A shares to specific targets during a board meeting on May 26, 2026. The plan requires further approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission. Investors are advised to review the details and remain aware of investment risks.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.